Related stories
Aptiv Reports Third-Quarter Sales of $3.2 Billion
M impact | EARNINGS | Nov 03, 2026, 11:53 AM UTC
Bayer Raises 2026 Profit Outlook as Pharma Beats Expectations
Bayer raised its 2026 profit outlook, citing stronger-than-expected performance in its pharmaceuticals business.
M impact | EARNINGS | Nov 03, 2026, 11:52 AM UTC
Alpha Dhabi Nine-Month Net Profit Rises 23% to $3.49 Billion
M impact | EARNINGS | Nov 03, 2026, 11:52 AM UTC
PJT Partners Reports Third-Quarter Net Income of $56 Million
L impact | EARNINGS | Nov 03, 2026, 11:52 AM UTC
PJT Partners Third-Quarter Net Income Falls 25% to $56.02 Million
M impact | EARNINGS | Nov 03, 2026, 11:51 AM UTC
Aptiv Beats Q3 EPS by $0.09, Guides Q4 EPS Below Consensus
Aptiv reported Q3 adjusted earnings of $1.42 per share, $0.09 above the comparison figure. Q3 revenue was in line; Q4 EPS guidance is below consensus, with revenue guidance in line
M impact | EARNINGS | Nov 03, 2026, 11:51 AM UTC